250 related articles for article (PubMed ID: 23643547)
1. Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size.
David E; Thall PF; Kalhor N; Hofstetter WL; Rice DC; Roth JA; Swisher SG; Walsh GL; Vaporciyan AA; Wei C; Mehran RJ
Ann Thorac Surg; 2013 Jun; 95(6):1872-7; discussion 1877. PubMed ID: 23643547
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
[TBL] [Abstract][Full Text] [Related]
3. Impact of visceral pleural invasion on the survival of patients with non-small cell lung cancer.
Kudo Y; Saji H; Shimada Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Lung Cancer; 2012 Nov; 78(2):153-60. PubMed ID: 22944144
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of visceral pleural involvement in early-stage lung cancer.
Lakha S; Gomez JE; Flores RM; Wisnivesky JP
Chest; 2014 Dec; 146(6):1619-1626. PubMed ID: 25032521
[TBL] [Abstract][Full Text] [Related]
5. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.
Manac'h D; Riquet M; Medioni J; Le Pimpec-Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2001 Apr; 71(4):1088-93. PubMed ID: 11308141
[TBL] [Abstract][Full Text] [Related]
6. Visceral pleural invasion classification in non-small-cell lung cancer in the 7th edition of the tumor, node, metastasis classification for lung cancer: validation analysis based on a large-scale nationwide database.
Kawase A; Yoshida J; Miyaoka E; Asamura H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
J Thorac Oncol; 2013 May; 8(5):606-11. PubMed ID: 23478542
[TBL] [Abstract][Full Text] [Related]
7. Subcategorization of lung cancer based on tumor size and degree of visceral pleural invasion.
Sakakura N; Mori S; Okuda K; Fukui T; Hatooka S; Shinoda M; Matsuo K; Yatabe Y; Yokoi K; Mitsudomi T
Ann Thorac Surg; 2008 Oct; 86(4):1084-90. PubMed ID: 18805136
[TBL] [Abstract][Full Text] [Related]
8. Visceral pleural invasion classification in non-small cell lung cancer.
Kawase A; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
J Thorac Oncol; 2010 Nov; 5(11):1784-8. PubMed ID: 20881646
[TBL] [Abstract][Full Text] [Related]
9. Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non-small cell lung cancer.
Tian D; Pei Y; Zheng Q; Zhang J; Li S; Wang X; Lin D; Yang Y
Thorac Cancer; 2017 Mar; 8(2):97-105. PubMed ID: 28256095
[TBL] [Abstract][Full Text] [Related]
10. Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment.
Shimizu K; Yoshida J; Nagai K; Nishimura M; Yokose T; Ishii G; Nishiwaki Y
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1574-8. PubMed ID: 15173709
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution.
Maruyama R; Shoji F; Okamoto T; Miyamoto T; Miyake T; Nakamura T; Ikeda J; Asoh H; Yamaguchi M; Yoshino I; Ichinose Y
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1587-92. PubMed ID: 15173711
[TBL] [Abstract][Full Text] [Related]
12. Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma.
Nitadori JI; Colovos C; Kadota K; Sima CS; Sarkaria IS; Rizk NP; Rusch VW; Travis WD; Adusumilli PS
Chest; 2013 Nov; 144(5):1622-1631. PubMed ID: 23807749
[TBL] [Abstract][Full Text] [Related]
13. Visceral pleural invasion remains a size-independent prognostic factor in stage I non-small cell lung cancer.
Huang H; Wang T; Hu B; Pan C
Ann Thorac Surg; 2015 Apr; 99(4):1130-9. PubMed ID: 25704861
[TBL] [Abstract][Full Text] [Related]
14. Impact of visceral pleural invasion on the association of extent of lymphadenectomy and survival in stage I non-small cell lung cancer.
Wo Y; Zhao Y; Qiu T; Li S; Wang Y; Lu T; Qin Y; Song G; Miao S; Sun X; Liu A; Kong D; Dong Y; Leng X; Du W; Jiao W
Cancer Med; 2019 Feb; 8(2):669-678. PubMed ID: 30706688
[TBL] [Abstract][Full Text] [Related]
15. Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer.
Seok Y; Jeong JY; Lee E
Thorac Cancer; 2017 May; 8(3):197-202. PubMed ID: 28220643
[TBL] [Abstract][Full Text] [Related]
16. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival.
Wightman SC; Lee JY; Ding L; Atay SM; Shemanski KA; McFadden PM; David EA; Kim AW
Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35325098
[TBL] [Abstract][Full Text] [Related]
18. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.
Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
Chest; 2011 Dec; 140(6):1494-1502. PubMed ID: 21622548
[TBL] [Abstract][Full Text] [Related]
20. Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set.
Fibla JJ; Cassivi SD; Brunelli A; Decker PA; Allen MS; Darling GE; Landreneau RJ; Putnam JB
Lung Cancer; 2012 Dec; 78(3):259-62. PubMed ID: 23040416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
